grepcent public filings, reorganized for comparison

AdvanSix Inc. (ASIX)

CIK: 0001673985. SIC: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers. Latest 10-K as of: 2026-02-20.

SIC breadcrumb: Manufacturing > Chemicals And Allied Products > SIC 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1673985. Latest filing source: 0001673985-26-000008.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-20 · accession 0001673985-26-000008 · source: SEC companyfacts

Revenue
1,522,233,000 USD verified
Net income
49,286,000 USD verified
Assets
1,706,148,000 USD verified
Free cash flow
6,418,000 USD computed
Net margin
3.24% computed
Revenue YoY
+0.31% computed
ROE
6.05% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

ASIX ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 2821; per-ratio N printed.ASIX ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 2821; per-ratio N printed.RatioASIXPeer medianPercentileNNet margin3.2%-6.1%759Revenue growth0.3%-2.3%759FCF margin0.4%4.1%3310ROE6.0%-5.2%759ROA2.9%-3.4%7810Liabilities / equity1.091.16389Current ratio1.132.10010

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue1,522,233,000USD20252026-02-20
Net income49,286,000USD20252026-02-20
Assets1,706,148,000USD20252026-02-20

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-20. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001673985.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric20152016201720182019202020212022202320242025
Revenue1,191,524,0001,475,194,0001,514,984,0001,157,917,0001,684,625,0001,945,640,0001,533,599,0001,517,557,0001,522,233,000
Net income34,147,000146,699,00066,244,00041,347,00046,077,000139,791,000171,886,00054,623,00044,149,00049,286,000
Diluted EPS1.124.722.141.431.644.815.921.951.621.80
Operating cash flow113,740,000134,607,000173,385,000120,385,000111,847,000218,849,000273,601,000117,550,000135,413,000122,863,000
Capital expenditures84,009,00086,438,000109,215,000150,322,00082,918,00056,811,00089,449,000107,377,000133,722,000116,445,000
Dividends paid0.000.003,518,00015,073,00016,657,00017,135,00017,176,000
Share buybacks0.000.0038,524,00062,196,0001,055,000652,00033,748,00046,151,00010,428,0001,658,000
Assets904,957,0001,050,274,0001,152,547,0001,235,969,0001,263,407,0001,311,999,0001,495,331,0001,496,020,0001,594,920,0001,706,148,000
Liabilities689,595,000673,949,000732,209,000835,091,000819,284,000710,809,000757,151,000756,783,000820,270,000890,932,000
Stockholders' equity482,809,000420,338,000444,123,000601,190,000738,180,000739,237,000774,650,000815,216,000
Cash and cash equivalents14,199,00055,432,0009,808,0007,050,00010,606,00015,100,00030,985,00029,768,00019,564,00019,766,000
Free cash flow29,731,00048,169,00064,170,000-29,937,00028,929,000162,038,000184,152,00010,173,0001,691,0006,418,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric20152016201720182019202020212022202320242025
Net margin2.87%9.94%4.37%3.98%8.30%8.83%3.56%2.91%3.24%
Return on equity15.76%10.37%23.25%23.29%7.39%5.70%6.05%
Return on assets3.77%13.97%5.75%3.35%3.65%10.65%11.49%3.65%2.77%2.89%
Liabilities / equity1.741.841.181.031.021.061.09
Current ratio1.031.311.001.001.161.131.121.171.081.13

Industry Peer Context

Each number-line places ASIX against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

ASIX Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 9.ASIX Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 9.9 SIC peersMin -18.3%Median -6.1%Max 5.8%ASIX 3.2%

ROE peer context

ASIX ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 9.ASIX ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 9.9 SIC peersMin -397.9%Median -5.2%Max 8.7%ASIX 6.0%

ROA peer context

ASIX ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 10.ASIX ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2821; peer count 10.10 SIC peersMin -23.9%Median -3.4%Max 4.0%ASIX 2.9%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

ASIX FY2025 free cash flow bridge from reported figures.ASIX FY2025 free cash flow bridge from reported figures.ASIX free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$122.9MOperating cash flow-$116.4MCapex$6.4MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001673985-26-000008; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001673985-26-000008; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001673985-26-000008; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

ASIX revenue, last 5 periods. Source: SEC companyfacts FY2025.ASIX revenue, last 5 periods. Source: SEC companyfacts FY2025.ASIX RevenueLatest point: FY2025 = $1.5BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: RevenueFromContractWithCustomerIncludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

ASIX net income, last 5 periods. Source: SEC companyfacts FY2025.ASIX net income, last 5 periods. Source: SEC companyfacts FY2025.ASIX Net incomeLatest point: FY2025 = $49.3MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

ASIX diluted eps, last 5 periods. Source: SEC companyfacts FY2025.ASIX diluted eps, last 5 periods. Source: SEC companyfacts FY2025.ASIX Diluted EPSLatest point: FY2025 = $1.80/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$4.00/share$8.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

ASIX operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.ASIX operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.ASIX Operating cash flowLatest point: FY2025 = $122.9MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

ASIX capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.ASIX capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.ASIX Capital expendituresLatest point: FY2025 = $116.4MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

ASIX dividends paid, last 5 periods. Source: SEC companyfacts FY2025.ASIX dividends paid, last 5 periods. Source: SEC companyfacts FY2025.ASIX Dividends paidLatest point: FY2025 = $17.2MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.

ASIX share buybacks, last 5 periods. Source: SEC companyfacts FY2025.ASIX share buybacks, last 5 periods. Source: SEC companyfacts FY2025.ASIX Share buybacksLatest point: FY2025 = $1.7MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

ASIX assets, last 5 periods. Source: SEC companyfacts FY2025.ASIX assets, last 5 periods. Source: SEC companyfacts FY2025.ASIX AssetsLatest point: FY2025 = $1.7BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: Assets. Source concepts: us-gaap:Assets.

ASIX liabilities, last 5 periods. Source: SEC companyfacts FY2025.ASIX liabilities, last 5 periods. Source: SEC companyfacts FY2025.ASIX LiabilitiesLatest point: FY2025 = $890.9MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

ASIX stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.ASIX stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.ASIX Stockholders' equityLatest point: FY2025 = $815.2MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

ASIX cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.ASIX cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.ASIX Cash and cash equivalentsLatest point: FY2025 = $19.8MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

ASIX free cash flow, last 5 periods. Source: SEC companyfacts FY2025.ASIX free cash flow, last 5 periods. Source: SEC companyfacts FY2025.ASIX Free cash flowLatest point: FY2025 = $6.4MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001673985-26-000008; filed 2026-02-20. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-07. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001673985.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-300.35reported discrete quarter
2023-Q12023-03-311.22reported discrete quarter
2023-Q22023-06-301.16reported discrete quarter
2023-Q32023-06-3032,728,000reported discrete quarter
2023-Q32023-09-30322,907,000-0.29reported discrete quarter
2023-Q42023-12-31382,208,000-5,082,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31336,829,000-17,396,000-0.65reported discrete quarter
2024-Q22024-03-31-17,396,000reported discrete quarter
2024-Q22024-06-30453,479,0001.43reported discrete quarter
2024-Q32024-06-3038,927,000reported discrete quarter
2024-Q32024-09-30398,187,0000.82reported discrete quarter
2024-Q42024-12-31329,062,000352,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31377,791,00023,344,0000.86reported discrete quarter
2025-Q22025-03-3123,344,000reported discrete quarter
2025-Q22025-06-30410,022,0001.15reported discrete quarter
2025-Q32025-06-3031,371,000reported discrete quarter
2025-Q32025-09-30374,473,000-0.10reported discrete quarter
2025-Q42025-12-31359,947,000-2,791,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31404,183,000-15,546,000-0.58reported discrete quarter
2026-Q22026-03-31-15,546,000reported discrete quarter
2026-Q22026-06-30421,284,0000.12reported discrete quarter

Quarterly Charts

ASIX quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX Quarterly RevenueLatest point: 2026-Q2 = $421.3MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$250.0M$500.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001673985-26-000049; filed 2026-08-07. Concept: RevenueFromContractWithCustomerIncludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

ASIX quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX Quarterly Net incomeLatest point: 2026-Q2 = -$15.5MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income-$250.0M$0.0B$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001673985-26-000037; filed 2026-05-08. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

ASIX quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.ASIX Quarterly Diluted EPSLatest point: 2026-Q2 = $0.12/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)-$1.00/share$0.00/share$2.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001673985-26-000049; filed 2026-08-07. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read ASIX's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read ASIX's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001673985-26-000049.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-07. Report date: 2026-06-30.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the financial condition and results of operations, of AdvanSix Inc. (“AdvanSix,” the “Company,” “we” or “our”), which we refer to as our “MD&A,” should be read in conjunction with the Condensed Consolidated Financial Statements and the notes thereto contained in this Quarterly Report on Form 10-Q (this "Form 10-Q"), as well as the MD&A section included in our Annual Report on Form 10-K for the year ended December 31, 2025 ("2025 Form 10-K"). Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors that can affect our performance in both the near- and long-term, including those incorporated by reference in Item 1A of Part II of this Form 10-Q as such factors may be revised or supplemented in subsequent filings with the SEC, as well as those discussed in the section entitled “Note Regarding Forward-Looking Statements” below.

Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this MD&A regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). When used in this Form 10-Q, words such as "expect," “anticipate,” "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should," and “believe,” and other variations or similar terminology and expressions identify forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in the Middle East, as well as any related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with potential use of artificial intelligence in our operations or those of third party service providers; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. Forward-looking statements are not guarantees of future performance and actual results could differ materially from those contemplated by the forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those detailed in Item 1A of Part I and elsewhere in our 2025 Form 10-K, and subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.

Business Overview

AdvanSix is a vertically integrated chemistry company that produces essential materials for diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and

17

deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients and chemical intermediates. Our key product lines are as follows:

•Nylon Solutions

◦Nylon – We sell our Nylon 6 resin globally, primarily under the Aegis® brand name. Nylon 6 is a polymer resin which is a synthetic material used by our customers to produce fibers, filaments, engineered plastics and films that, in turn, are used in such end-products as carpets, automotive and electric components, sports apparel, food packaging and other industrial applications.

◦Caprolactam – Caprolactam is the key monomer used in the production of Nylon 6 resin. We internally polymerize caprolactam into Aegis® Nylon 6 Resin, and we also market and sell the caprolactam that is not consumed internally to customers who use it to manufacture polymer resins to produce fibers, compounds and other nylon products. Our Hopewell, VA manufacturing facility is one of the world’s largest single-site producers of caprolactam as of June 30, 2026.

•Plant Nutrients – Our ammonium sulfate is used by customers as a fertilizer containing nitrogen and sulfur, two key plant nutrients. Ammonium sulfate fertilizer is derived from the integrated operations at the Hopewell manufacturing facility. Because of our Hopewell facility’s size, scale and technology design, we are the world’s largest single-site producer of ammonium sulfate fertilizer as of June 30, 2026. We market and sell ammonium sulfate primarily to North American and South American distributors, farm cooperatives and retailers to fertilize crops. We also manufacture sulfuric acid, ammonia and carbon dioxide as part of our integrated operations at Hopewell and occasionally sell any excess material not consumed internally to customers externally.

•Chemical Intermediates – We manufacture, market and sell a number of chemical intermediate products that are derived from the manufacturing processes within our integrated supply chain. Most significant is acetone which is used by our customers in the production of solvents, paints, coatings, adhesives, resins and herbicides. Other intermediate chemicals that we manufacture, market and sell include phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl-amines and specialty amines. Additional end-products for intermediates include automotive components, and water treatment and pharmaceutical intermediates.

The primary raw material used in our manufacturing process is cumene, which is produced from benzene and propylene. We purchase cumene from multiple suppliers to ensure stability of supply and optimal terms. Other important raw materials used in our manufacturing process are natural gas and sulfur, which are used to produce caprolactam and ammonium sulfate. We purchase natural gas and sulfur from a diverse set of suppliers.

Historically, we have been able to renew contracts with our suppliers and obtain sufficient quantities of cumene, sulfur, natural gas and any other key raw materials. Global supply and demand can significantly impact the price of our key raw materials, and historically prices have been cyclical. Prices for our key raw materials are typically on a monthly settlement basis for benzene, propylene and natural gas, or on a quarterly settlement basis for sulfur. We mitigate our exposure to commodity price risk primarily through the use of medium- and long-term, formula-based price contracts with our suppliers and formula-based price agreements with customers which structurally pass through increases or decreases in raw material costs. While formula or index-based pricing agreements are more common for benzene and propylene across our Nylon Solutions and Chemical Intermediates portfolio, a portion of our natural gas and sulfur exposure is also structurally passed through in certain customer agreements. Sales in our Plant Nutrients business line are priced on a freely negotiated basis.

Global demand for Nylon 6 resin spans a variety of end-uses such as textiles, engineered plastics, industrial filament, food and industrial films, and carpet. The market growth typically tracks global GDP growth over the long-term but varies by end-use. We produce and sell caprolactam as a commodity product and produce and sell our Nylon 6 resin as both a commoditized and differentiated resin product. Our results of operations are primarily driven by production volume and the spread between the sales prices of our products and the costs of the underlying raw materials built into market-based and value-based pricing models. The global prices for nylon resin typically track as a spread over the price of caprolactam, which in turn tracks as a spread over benzene because the key feedstock materials for caprolactam, phenol or cyclohexane, are derived from benzene. This price spread has historically experienced cyclicality as a result of global changes in supply and demand. Generally, Nylon 6 resin prices track the cyclicality of capro

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001673985-26-000008. The complete FY 2025 MD&A is published at /company/ASIX/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-02-20. Report date: 2025-12-31.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

(Dollars in thousands, except per share data or unless otherwise noted)

The following section, referred to as the "MD&A" presents management's discussion and analysis of the Company's financial condition and results of operations and should be read in conjunction with the Consolidated Financial Statements and the notes thereto contained in this Form 10-K. This section of this Form 10-K generally discusses our financial condition and results of operations as of and for the years ended December 31, 2025 and 2024 and year-to-year comparisons between 2025 and 2024. Discussions of our financial condition and results of operations as of and for the year ended December 31, 2023 and year-to-year comparisons between

28

2024 and 2023 that are not included in this Form 10-K can be found under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 21, 2025.

Business Overview

AdvanSix Inc. is an integrated chemistry company that produces essential materials for our customers across diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients and chemical intermediates, guided by our core values of Safety, Integrity, Accountability and Respect. Our four key product lines are Nylon, Caprolactam, Ammonium Sulfate and Chemical Intermediates.

Global demand for Nylon 6 resin spans a variety of end-uses such as textiles, engineered plastics, industrial filament, food and industrial films, and carpet. The market growth typically tracks global GDP growth over the long-term but varies by end-use. We produce and sell caprolactam as a commodity product and produce and sell our Nylon 6 resin as both a commoditized and differentiated resin product. Our results of operations are primarily driven by production volume and the spread between the sales prices of our products and the costs of the underlying raw materials built into market-based and value-based pricing models. The global prices for nylon resin typically track a spread over the price of caprolactam, which in turn tracks as a spread over benzene because the key feedstock materials for caprolactam, phenol or cyclohexane, are derived from benzene. This price spread has historically experienced cyclicality as a result of global changes in supply and demand. Generally, Nylon 6 resin prices track the cyclicality of caprolactam prices, although prices set above the spread are achievable when nylon resin manufacturers, like AdvanSix, formulate and produce differentiated nylon resin products for current and new customer applications, such as our wire and cable and co-polymer offerings.

Global prices for ammonium sulfate fertilizer are influenced by several factors including the price of urea, which is the most widely used source of nitrogen-based fertilizer in the world. Other global factors driving ammonium sulfate fertilizer demand are general agriculture trends, including planted acres and the price of crops. Our ammonium sulfate product is positioned with the added value proposition of sulfur nutrition to increase yields of key crops. In addition, due to its nutrient density, the typical ammonium sulfate product delivers pound for pound the most readily available sulfur and nitrogen to crops as compared to other fertilizers. We also directly supply packaged ammonium sulfate to customers, primarily in North and South America, and have diversified and optimized our offerings to include spray-grade adjuvants to support crop protection, as well as other specialty fertilizers and products for industrial use.

Our ammonium sulfate fertilizer experiences quarterly sales seasonality reflecting both geographical and product sales mix considerations based on the timing and length of the growing seasons in North and South America. The North American fertilizer season typically runs from July, when the value chain begins restocking fertilizer, through June of the following year, when most application for the year’s planting is completed. The new season fill begins in the third quarter and proceeds sequentially into the following spring, which is the peak period for crop fertilizer application. As a result of this pattern, North American ammonium sulfate demand and pricing, particularly for our higher-value granular product, are typically strongest in the first half of the year through application for the spring crop and then decline in the second half of the year. Ammonium sulfate industry prices in the corn belt have declined approximately 12% from the second quarter to the third quarter, on average, since 2016. Due to the ammonium sulfate fertilizer sales cycle, we occasionally build up higher inventory balances because our production is continuous throughout the year and not tied to seasonal demand for fertilizers. Sales of most of our other products have generally been subject to minimal, or no, seasonality.

We also manufacture, market and sell a number of chemical intermediate products that are derived from the manufacturing processes within our integrated supply chain. Most significant is acetone, the price of which is influenced by its own supply and demand dynamics but can also be influenced by the underlying move in propylene input costs. Our differentiated product offerings include high-purity applications and high-value intermediates including our U.S. Amines portfolio as well as our oximes-based EZ-Blox™ anti-skinning agent used in paints and Nadone® cyclohexanone, which is a solvent used in various high-value applications.

We seek to run our production facilities on a nearly continuous basis for maximum efficiency as several of our intermediate products are key feedstock materials for other products in our integrated manufacturing chain. While our integration, scale and range of product offerings make us one of the most efficient manufacturers in our industry, these attributes also expose us to increased risk associated with material disruptions at any one of our production facilities or logistics operations which could impact the overall manufacturing supply chain. Further, although we believe that our sources of supply for our raw materials, including cumene, natural gas and sulfur, are generally robust, it is difficult to predict the impact that shortages, increased costs and related supply chain logistics considerations may have in the future. In order to mitigate the risk of unplanned interruptions, we schedule several planned plant turnarounds each year to conduct routine and major maintenance across our facilities. We also utilize maintenance excellence and mechanical integrity

29

programs, targeted buffer inventory of intermediate chemicals necessary for our manufacturing process, and co-producer swap arrangements, which are intended to mitigate the extent of any production losses as a result of planned and unplanned downtime; however, the mitigation of all or part of any such production impact cannot be assured. For a description of our principal risks, see “Risk Factors" in Item 1A.

Recent Developments

Frankford, PA Collective Bargaining Agreement

On November 12, 2025, the Company’s Frankford bargaining unit, represented by the United Steelworkers Local No. 10-667, ratified a new four-year labor agreement. The ratified labor agreement affected approximately 100 workers at the Company’s manufacturing facility in Frankford, Pennsylvania.

Amendment to Credit Agreement

On October 23, 2025, the Company entered into Amendment No. 2 (the “Amendment”) to the Credit Agreement (as defined below). See “Liquidity and Capital Resources - Credit Agreement” for a discussion regarding the Amendment.

Succession of Chief Financial Officer

Effective as of July 9, 2025, the Board appointed Christopher Gramm as Interim Chief Financial Officer.

Anti-Dumping Duty Petition - Acetone

On November 4, 2024, the U.S. Department of Commerce ("Commerce") initiated the first five-year review of the anti-dumping orders on imports of acetone from Belgium, Singapore, South Africa, South Korea, and Spain. On November 1, 2024, the U.S. International Trade Commission ("ITC") issued its notice of initiation of its five-year review of the orders. The anti-dumping orders and applicable duties will continue for another five-year period if Commerce finds that revocation of the orders is likely to lead to continuation or recurrence of dumping and if the ITC finds that revocation is likely to lead to continuation or recurrence of material injury to the U.S. domestic industry. On December 26, 2024, Commerce notified the ITC that it would conduct an expedited review and issue its results no later than March 4, 2025. On February 4, 2025, the ITC voted to conduct a full review and is expected to issue its results in the fourth quarter of 2025. On March 7, 2025, Commerce determined that revocation of the anti-dumping orders would likely lead to continuation of recurrence of dumping. In January 2026, the ITC made affirmative determinations that revocation of the orders would likely lead to continuation or recurrence of material inquiry. As a result of the Commerce and ITC's determinations, the orders will be extended for another five years.

Philadelphia Energy Solutions’ Shut Down

The Company previously reported a business impact associated with the June 2019 fire that shut down the Philadelphia Energy Solutions (“PES”) refinery in Philadelphia, Pennsylvania. PES was one of multiple suppliers to the Company of cumene, a feedstock material used to produce phenol, acetone and other chemical intermediates. The Company was actively pursuing a business interruption claim over several years, with a final omnibus settlement in January 2025 which resulted in insurance settlement proceeds of approximately $26 million in the first quarter of 2025. The total aggregate insurance proceeds since the original claim submission are approximately $39 million.

Consolidated Results of Operations for the Years Ended December 31, 2025, 2024 and 2023

(Dollars in thousands)

Sales

202520242023
Sales$1,522,233$1,517,557$1,533,599
% change compared with prior period0.3%(1.0)%(21.2)%

The change in sales is attributable to the following:

2025 versus 20242024 versus 2023
Volume0.8%(1.9)%
Price(0.5)%0.9%
0.3%(1.0)%

30

2025 compared with 2024

Sales were essentially flat in 2025 compared to 2024 due to increased volume (approximately 1%) primarily driven by higher granular ammonium sulfate sales supported by our SUSTAIN (Sustainable U.S. Sulfate to Accelerate Increased Nutrition) program offset by decreased net pricing (approximately 0.5%) reflecting lower raw material pass through pricing on lower benzene input costs and favorable market-based pricing across our Plant Nutrients and Nylon Solutions product lines.

Cost of Goods Sold

202520242023
Cost of goods sold$1,357,293$1,364,621$1,368,511
% change compared with prior period(0.5)%(0.3)%(16.1)%
Gross margin %10.8%10.1%10.8%

2025 compared w

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for ASIX

Indicators mapped to this company's SIC classification (industry 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Inflation (CPI / PCE / PPI), US labor market, Growth & output, Money & trade, Government finances, Sector employment, Industrial orders & inventories, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/ASIX.md · JSON record: /company/ASIX.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt